Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats (Q44006657)

28 November 2017

title

Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats (English)

1 reference

28 November 2017

1 reference

Wayne A Cass

1 reference

28 November 2017

Michael E Harned

series ordinal

1 reference

28 November 2017

Sherry L Bailey

series ordinal

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

28 November 2017

1 reference

28 November 2017

volume

938

1 reference

28 November 2017

issue

1-2

1 reference

28 November 2017

page(s)

29-37

1 reference

Effect of aging on dopaminergic receptors and uptake sites in the rat brain studied by receptor autoradiography

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Prevalence of parkinsonian signs and associated mortality in a community population of older people

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

6-hydroxydopamine induces the loss of the dopaminergic phenotype in substantia nigra neurons of the rat. A possible mechanism for restoration of the nigrostriatal circuit mediated by glial cell line-derived neurotrophic factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Effects of intra-striatal GDNF on motor coordination and striatal electrophysiology in aged F344 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

GDNF selectively protects dopamine neurons over serotonin neurons against the neurotoxic effects of methamphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Clearance of exogenous dopamine in rat dorsal striatum and nucleus accumbens: role of metabolism and effects of locally applied uptake inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Effects of age and available response time on ability to step over an obstacle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Changes in dopamine release in vitro from the corpus striatum of young versus aged rats as a function of infusion modes of L-dopa, potassium, and amphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Restriction and functional changes of dopamine release in rat striatum from young adult and old rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Locomotion of aged rats: relationship to neurochemical but not morphological changes in nigrostriatal dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Ageing and Parkinson's disease: substantia nigra regional selectivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Neuroprotective effects of GDNF against 6-OHDA in young and aged rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Age differences and changes in reaction time: the Baltimore Longitudinal Study of Aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Regional effects of aging on dopaminergic function in the Fischer-344 rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Dopamine release and uptake rates both decrease in the partially denervated striatum in proportion to the loss of dopamine terminals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Nafion-coated electrodes with high selectivity for CNS electrochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Exaggerated astrocyte reactivity after nigrostriatal deafferentation in the aged rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Decline in striatal dopamine D1 and D2 receptor activation in aged F344 rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

In vivo assessment of striatal dopamine release in the aged male Fischer 344 rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Neurologic evaluation of the optimally healthy oldest old.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Aging produces a specific pattern of striatal dopamine loss: implications for the etiology of idiopathic Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Incomplete nigrostriatal dopaminergic cell loss and partial reductions in striatal dopamine produce akinesia, rigidity, tremor and cognitive deficits in middle-aged rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

In vivo electrochemical measurements and electrophysiological studies of rat striatum following neonatal 6-hydroxydopamine treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Dopamine transporter-immunoreactive neurons decrease with age in the human substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Recovery of function after mesotelencephalic dopaminergic injury in senescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Aging and Extrapyramidal Function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

The dopamine-depleting effect of 6-hydroxydopamine does not increase with aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Expression of superoxide dismutase and catalase in rat brain as a function of age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Relationship between [3H]mazindol binding to dopamine uptake sites and [3H]dopamine uptake in rat striatum during aging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

In vivo microdialysis studies of age-related alterations in potassium-evoked overflow of dopamine in the dorsal striatum of Fischer 344 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Uptake of dopamine released by impulse flow in the rat mesolimbic and striatal systems in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Geriatrics: gait disorders in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2902481-2

10.1016/S0006-8993(02)02481-2

7 January 2021

Identifiers

DOI

1 reference

28 November 2017

1 reference